KURA - Kura Oncology Inc
Kura Oncology Inc Logo

KURA - Kura Oncology Inc

https://kuraoncology.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California.

52W High
$21.40
52W Low
$5.41
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.19
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.48
EV/Revenue (<3 favorable)
1.23
P/S (TTM) (<3 favorable)
8.57
P/B (<3 favorable)
2.34
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
1.15%
Institutions (25–75% balanced)
95.88%
Shares Outstanding
86,797,000
Float
63,986,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
83,279,000
Gross Profit (TTM)
-114,831,000
EPS (TTM)
-2.25
Profit Margin (>10% good)
-2.37%
Operating Margin (TTM) (higher better)
-4.75%
ROE (TTM) (>15% strong)
-0.51%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.5864
Previous
0.5884
Trend
Falling
Signal Cross
No cross
As of
Sep. 05, 2025